Your browser doesn't support javascript.
loading
Neoadjuvant chemotherapy improves survival in patients with oesophageal mucinous adenocarcinoma: Post-hoc analysis of the UK MRC OE02 and OE05 trials.
Liu, Drolaiz H W; Sefcovicová, Nina; Emmerson, Jake; Spaans, Louisa N; Saito, Yuichi; Hutchins, Gordon; Nankivell, Matthew G; Langley, Ruth E; Allum, William; Cunningham, David; Langer, Rupert; Grabsch, Heike I.
Afiliação
  • Liu DHW; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands; Institute of Clinical Pathology and Molecular Pathology, Kepler University Hospital and Johannes Kepler University, Linz, Austria.
  • Sefcovicová N; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands.
  • Emmerson J; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Spaans LN; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands; Department of Surgery, Maxima Medical Centre, Eindhoven/Veldhoven, the Netherlands.
  • Saito Y; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands; Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan.
  • Hutchins G; Division of Pathology and Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
  • Nankivell MG; Medical Research Council Clinical Trials Unit at University College London, London, UK.
  • Langley RE; Medical Research Council Clinical Trials Unit at University College London, London, UK.
  • Allum W; Department of Oncology and Department of Surgery, Royal Marsden NHS Foundation Trust, London, UK.
  • Cunningham D; Department of Medicine, Royal Marsden Hospital, Sutton, Surrey, UK.
  • Langer R; Institute of Clinical Pathology and Molecular Pathology, Kepler University Hospital and Johannes Kepler University, Linz, Austria.
  • Grabsch HI; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands; Division of Pathology and Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK. Electronic address: h.grabsch@maastrich
Eur J Cancer ; 170: 140-148, 2022 07.
Article em En | MEDLINE | ID: mdl-35635935
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Adenocarcinoma / Adenocarcinoma Mucinoso Tipo de estudo: Prognostic_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Adenocarcinoma / Adenocarcinoma Mucinoso Tipo de estudo: Prognostic_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article